Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
T. Futami(The University of Tokyo), Sadao Kuromitsu(Astellas Pharma (Japan))
Cited by 16
Related Papers
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
|Investigational New Drugs|2017|254
Identification of a Network Involved in Thapsigargin-induced Apoptosis Using a Library of Small Interfering RNA Expression Vectors*[boxs]
|Journal of Biological Chemistry|2004|83